BlackRock
CNTB

BlackRock’s Connect Biopharma Holdings CNTB Stock Holding History

BlackRock’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07M Buy
+871,653
New +$2.11M ﹤0.01% 4147
2024
Q4 		– Sell
-1,838
Closed -$2.65K – 5402
2024
Q3 		$2.65K Sell
1,838
-102,053
-98% -$125K ﹤0.01% 5095
2024
Q2 		$158K Sell
103,891
-936,176
-90% -$1.54M ﹤0.01% 4594
2024
Q1 		$1.81M Hold
1,040,067
– – ﹤0.01% 4032
2023
Q4 		$1.23M Sell
1,040,067
-85,195
-8% -$101K ﹤0.01% 4197
2023
Q3 		$922K Hold
1,125,262
– – ﹤0.01% 4271
2023
Q2 		$1.27M Hold
1,125,262
– – ﹤0.01% 4221
2023
Q1 		$1.13M Hold
1,125,262
– – ﹤0.01% 4300
2022
Q4 		$977K Sell
1,125,262
-301,166
-21% -$248K ﹤0.01% 4419
2022
Q3 		$1.84M Sell
1,426,428
-8,532
-0.6% -$10.3K ﹤0.01% 4232
2022
Q2 		$1.25M Sell
1,434,960
-801,432
-36% -$1.18M ﹤0.01% 4443
2022
Q1 		$6.75M Buy
2,236,392
+92,632
+4% +$391K ﹤0.01% 3789
2021
Q4 		$11M Sell
2,143,760
-306,305
-13% -$3.4M ﹤0.01% 3615
2021
Q3 		$59.4M Sell
2,450,065
-8,067
-0.3% -$183K ﹤0.01% 2549
2021
Q2 		$48M Buy
2,458,132
+7,742
+0.3% +$129K ﹤0.01% 2731
2021
Q1 		$45.3M Buy
+2,450,390
New +$41.7M ﹤0.01% 2682

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

BlackRock's CNTB Position: Q2 2026 in Review

BlackRock opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 871,653 shares worth $2.07M. The stake represents ﹤0.01% of the portfolio and ranks #4147 among its holdings. This is a return to the name: BlackRock previously reported a position in CNTB as recently as Q3 2024.

BlackRock first reported a position in CNTB in Q1 2021 and has held it in 16 quarters since. The position peaked at $59.4M in Q3 2021. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • BlackRock held 871,653 shares of Connect Biopharma Holdings worth $2.07M as of Q2 2026.
  • Connect Biopharma Holdings was a new BlackRock position in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4147 holding.
  • BlackRock first reported a position in Connect Biopharma Holdings in Q1 2021 and has held it in 16 quarters since.
  • BlackRock's Connect Biopharma Holdings position peaked at $59.4M in Q3 2021.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.